Browse the full record of transactions filed by KANAYA SUSAN M, Chief Financial Officer. Director active across 1 companies, notably ChemoCentryx, Inc.. In total, 2 filings have been recorded. The latest transaction was disclosed on 1 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Susan M. Kanaya is the Executive Vice President, Chief Financial Officer, and Secretary at ChemoCentryx, Inc. In this role, she is responsible for the financial management of the company, including financial planning and compliance. Her expertise in finance and accounting is essential to ensure the financial health of ChemoCentryx. Susan M. Kanaya plays a key role in making strategic financial decisions and optimizing the company's performance.